SCHEMBL24738599

SCHEMBL24738599

CN1CC(=O)N(CCO)C1=O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.49
HDAC6 Q9UBN7 1/20 0.44
ALDH1A1 P00352 4/20 0.43
RECQL P46063 1/20 0.43
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
GFER P55789 1/20 0.38
BRD4 O60885 2/20 0.37
GAA P10253 2/20 0.35
GRM2 Q14416 2/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ATAD2 Q6PL18 1/20 0.33
KDM4E B2RXH2 1/20 0.32
PDE7A Q13946 1/20 0.32
HEXA P06865 1/20 0.32
HEXB P07686 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9190811 0.88 PLA2G7 (0.46) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL11466101 0.84 PLA2G7 (0.46) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL4447273 0.80 PLA2G7 (0.50) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL25000505 0.79 POLB (0.37) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL7291993 0.78 PLA2G7 (0.49) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL22702280 0.78 PLA2G7 (0.49) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL8827200 0.78 HDAC6 (0.37) PLA2G7HDAC6KMT2AKDM4EHEXA
SCHEMBL10969304 0.78 PLA2G7 (0.49) PLA2G7HDAC6ALDH1A1RECQLKMT2A
SCHEMBL29303859 0.78 HDAC6 (0.38) PLA2G7HDAC6ALDH1A1KMT2AMEN1
SCHEMBL414553 0.77 F2 (0.48) PLA2G7HDAC6ALDH1A1RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023134629-A1 NUCLEAR TRANSPORT REGULATOR AND USE THEREOF 上海海雁医药科技有限公司 2023-07-20 WO disclosed
WO-2022197758-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2022-09-22 WO disclosed